Immune responses to HER2, another molecule of the ErbB/HER onocogene family, have been well studied (Chapman et al., 2008; Knutson et al., 2016; Tabuchi et al., 2016), but only limited information on the immune responses to EGFR in cancer has been currently available. Here, EGFR is linked to cancer.